APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioanalytical Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bioanalytical Testing Market Outlook and Growth Opportunities 2026

3 May 2026197 pages

Choose your research edition.

Industry ResearchBioanalytical Testing Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioanalytical Testing Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Bioanalytical Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioanalytical Testing Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioanalytical Testing Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bioanalytical Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bioanalytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioanalytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioanalytical Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bioanalytical Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bioanalytical Testing market include Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions and WuXi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bioanalytical Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioanalytical Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioanalytical Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bioanalytical Testing market.

Bioanalytical Testing Segment by Company

Eurofins Scientific

Charles River

LabCorp

Altasciences

Intertek

Celerion

ACM Global Laboratories

Q2 Solutions

WuXi AppTec

SGS

Ardena

VTT

ICON

Simbec-Orion

Medpace

Frontage

Pharmaron

Veeda

GenScript

Sino Biological

Tigermed

Medicilon

Scinovo

Bioanalytical Testing Segment by Type

Small Molecule Bioanalysis

Large Molecule Bioanalysis

Biomarkers

Biologics and Vaccines

Bioanalytical Testing Segment by Application

Clinical

Non-clinical

Bioanalytical Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bioanalytical Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bioanalytical Testing key companies, revenue, market share, and recent developments.

3. To split the Bioanalytical Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bioanalytical Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bioanalytical Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Bioanalytical Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioanalytical Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioanalytical Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioanalytical Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioanalytical Testing industry.

Chapter 3: Detailed analysis of Bioanalytical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bioanalytical Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bioanalytical Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bioanalytical Testing Industry Trends Table 2. Bioanalytical Testing Industry Drivers Table 3. Bioanalytical Testing Industry Opportunities and Challenges Table 4. Bioanalytical Testing Industry Restraints Table 5. Global Bioanalytical Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bioanalytical Testing Revenue Share by Company (2021-2026) Table 7. Global Bioanalytical Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bioanalytical Testing Key Company Manufacturing Base & Headquarters Table 9. Global Bioanalytical Testing Company, Product Type & Application Table 10. Global Bioanalytical Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bioanalytical Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Small Molecule Bioanalysis Table 15. Significant Companies of Large Molecule Bioanalysis Table 16. Significant Companies of Biomarkers Table 17. Significant Companies of Biologics and Vaccines Table 18. Global Bioanalytical Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Bioanalytical Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Bioanalytical Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Bioanalytical Testing Sales Value Share by Type (2021-2026) Table 22. Global Bioanalytical Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Clinical Table 24. Significant Companies of Non-clinical Table 25. Global Bioanalytical Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bioanalytical Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Bioanalytical Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Bioanalytical Testing Sales Value Share by Application (2021-2026) Table 29. Global Bioanalytical Testing Sales Value Share by Application (2027-2032) Table 30. Global Bioanalytical Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Bioanalytical Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Bioanalytical Testing Sales Value Share by Region (2021-2026) Table 33. Global Bioanalytical Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Bioanalytical Testing Sales Value Share by Region (2027-2032) Table 35. Global Bioanalytical Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Bioanalytical Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Bioanalytical Testing Sales Value Market Share by Country (2021-2026) Table 38. Global Bioanalytical Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Bioanalytical Testing Sales Value Market Share by Country (2027-2032) Table 40. Eurofins Scientific Company Information Table 41. Eurofins Scientific Business Overview Table 42. Eurofins Scientific Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Eurofins Scientific Bioanalytical Testing Product Portfolio Table 44. Eurofins Scientific Recent Development Table 45. Charles River Company Information Table 46. Charles River Business Overview Table 47. Charles River Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Charles River Bioanalytical Testing Product Portfolio Table 49. Charles River Recent Development Table 50. LabCorp Company Information Table 51. LabCorp Business Overview Table 52. LabCorp Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. LabCorp Bioanalytical Testing Product Portfolio Table 54. LabCorp Recent Development Table 55. Altasciences Company Information Table 56. Altasciences Business Overview Table 57. Altasciences Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Altasciences Bioanalytical Testing Product Portfolio Table 59. Altasciences Recent Development Table 60. Intertek Company Information Table 61. Intertek Business Overview Table 62. Intertek Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Intertek Bioanalytical Testing Product Portfolio Table 64. Intertek Recent Development Table 65. Celerion Company Information Table 66. Celerion Business Overview Table 67. Celerion Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Celerion Bioanalytical Testing Product Portfolio Table 69. Celerion Recent Development Table 70. ACM Global Laboratories Company Information Table 71. ACM Global Laboratories Business Overview Table 72. ACM Global Laboratories Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. ACM Global Laboratories Bioanalytical Testing Product Portfolio Table 74. ACM Global Laboratories Recent Development Table 75. Q2 Solutions Company Information Table 76. Q2 Solutions Business Overview Table 77. Q2 Solutions Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Q2 Solutions Bioanalytical Testing Product Portfolio Table 79. Q2 Solutions Recent Development Table 80. WuXi AppTec Company Information Table 81. WuXi AppTec Business Overview Table 82. WuXi AppTec Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. WuXi AppTec Bioanalytical Testing Product Portfolio Table 84. WuXi AppTec Recent Development Table 85. SGS Company Information Table 86. SGS Business Overview Table 87. SGS Bioanalytical Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. SGS Bioanalytical Testing Product Portfolio Table 89. SGS Recent Development Table 90. Ardena Company Information Table 91. Ardena Business Overview Table 92. Ardena Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Ardena Bioanalytical Testing Product Portfolio Table 94. Ardena Recent Development Table 95. VTT Company Information Table 96. VTT Business Overview Table 97. VTT Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. VTT Bioanalytical Testing Product Portfolio Table 99. VTT Recent Development Table 100. ICON Company Information Table 101. ICON Business Overview Table 102. ICON Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. ICON Bioanalytical Testing Product Portfolio Table 104. ICON Recent Development Table 105. Simbec-Orion Company Information Table 106. Simbec-Orion Business Overview Table 107. Simbec-Orion Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Simbec-Orion Bioanalytical Testing Product Portfolio Table 109. Simbec-Orion Recent Development Table 110. Medpace Company Information Table 111. Medpace Business Overview Table 112. Medpace Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Medpace Bioanalytical Testing Product Portfolio Table 114. Medpace Recent Development Table 115. Frontage Company Information Table 116. Frontage Business Overview Table 117. Frontage Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Frontage Bioanalytical Testing Product Portfolio Table 119. Frontage Recent Development Table 120. Pharmaron Company Information Table 121. Pharmaron Business Overview Table 122. Pharmaron Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Pharmaron Bioanalytical Testing Product Portfolio Table 124. Pharmaron Recent Development Table 125. Veeda Company Information Table 126. Veeda Business Overview Table 127. Veeda Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Veeda Bioanalytical Testing Product Portfolio Table 129. Veeda Recent Development Table 130. GenScript Company Information Table 131. GenScript Business Overview Table 132. GenScript Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. GenScript Bioanalytical Testing Product Portfolio Table 134. GenScript Recent Development Table 135. Sino Biological Company Information Table 136. Sino Biological Business Overview Table 137. Sino Biological Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Sino Biological Bioanalytical Testing Product Portfolio Table 139. Sino Biological Recent Development Table 140. Tigermed Company Information Table 141. Tigermed Business Overview Table 142. Tigermed Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. Tigermed Bioanalytical Testing Product Portfolio Table 144. Tigermed Recent Development Table 145. Medicilon Company Information Table 146. Medicilon Business Overview Table 147. Medicilon Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Medicilon Bioanalytical Testing Product Portfolio Table 149. Medicilon Recent Development Table 150. Scinovo Company Information Table 151. Scinovo Business Overview Table 152. Scinovo Bioanalytical Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Scinovo Bioanalytical Testing Product Portfolio Table 154. Scinovo Recent Development Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Bioanalytical Testing Product Image Figure 2. Global Bioanalytical Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioanalytical Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioanalytical Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Small Molecule Bioanalysis Image Figure 8. Large Molecule Bioanalysis Image Figure 9. Biomarkers Image Figure 10. Biologics and Vaccines Image Figure 11. Global Bioanalytical Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Bioanalytical Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Bioanalytical Testing Sales Value Share by Type (2021-2032) Figure 14. Clinical Image Figure 15. Non-clinical Image Figure 16. Global Bioanalytical Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bioanalytical Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Bioanalytical Testing Sales Value Share by Application (2021-2032) Figure 19. Global Bioanalytical Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Bioanalytical Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Bioanalytical Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America Bioanalytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Bioanalytical Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Bioanalytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Bioanalytical Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Bioanalytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Bioanalytical Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America Bioanalytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Bioanalytical Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Bioanalytical Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Bioanalytical Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Biomarkers
  • Biologics and Vaccines
Applications
  • Clinical
  • Non-clinical
Companies covered
  • Eurofins Scientific
  • Charles River
  • LabCorp
  • Altasciences
  • Intertek
  • Celerion
  • ACM Global Laboratories
  • Q2 Solutions
  • WuXi AppTec
  • SGS
  • Ardena
  • VTT
  • ICON
  • Simbec-Orion
  • Medpace
  • Frontage
  • Pharmaron
  • Veeda
  • GenScript
  • Sino Biological
  • Tigermed
  • Medicilon
  • Scinovo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioanalytical Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioanalytical Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bioanalytical Testing Market Dynamics
  1. 2.1 Bioanalytical Testing Industry Trends
  2. 2.2 Bioanalytical Testing Industry Drivers
  3. 2.3 Bioanalytical Testing Industry Opportunities and Challenges
  4. 2.4 Bioanalytical Testing Industry Restraints
3 Bioanalytical Testing Market by Company
  1. 3.1 Global Bioanalytical Testing Company Revenue Ranking in 2025
  2. 3.2 Global Bioanalytical Testing Revenue by Company (2021-2026)
  3. 3.3 Global Bioanalytical Testing Company Ranking (2024-2026)
  4. 3.4 Global Bioanalytical Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Bioanalytical Testing Company Product Type and Application
  6. 3.6 Global Bioanalytical Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bioanalytical Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bioanalytical Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bioanalytical Testing Market by Type
  1. 4.1 Bioanalytical Testing Type Introduction
  2. 4.1.1 Small Molecule Bioanalysis
  3. 4.1.2 Large Molecule Bioanalysis
  4. 4.1.3 Biomarkers
  5. 4.1.4 Biologics and Vaccines
  6. 4.2 Global Bioanalytical Testing Sales Value by Type
  7. 4.2.1 Global Bioanalytical Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Bioanalytical Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Bioanalytical Testing Sales Value Share by Type (2021-2032)
5 Bioanalytical Testing Market by Application
  1. 5.1 Bioanalytical Testing Application Introduction
  2. 5.1.1 Clinical
  3. 5.1.2 Non-clinical
  4. 5.2 Global Bioanalytical Testing Sales Value by Application
  5. 5.2.1 Global Bioanalytical Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bioanalytical Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Bioanalytical Testing Sales Value Share by Application (2021-2032)
6 Bioanalytical Testing Regional Value Analysis
  1. 6.1 Global Bioanalytical Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioanalytical Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bioanalytical Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bioanalytical Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioanalytical Testing Sales Value (2021-2032)
  7. 6.3.2 North America Bioanalytical Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bioanalytical Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Bioanalytical Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bioanalytical Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bioanalytical Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bioanalytical Testing Sales Value (2021-2032)
  16. 6.6.2 South America Bioanalytical Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bioanalytical Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bioanalytical Testing Sales Value Share by Country, 2025 VS 2032
7 Bioanalytical Testing Country-level Value Analysis
  1. 7.1 Global Bioanalytical Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bioanalytical Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bioanalytical Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bioanalytical Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bioanalytical Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bioanalytical Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bioanalytical Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Bioanalytical Testing Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Charles River
  8. 8.2.1 Charles River Company Information
  9. 8.2.2 Charles River Business Overview
  10. 8.2.3 Charles River Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Bioanalytical Testing Product Portfolio
  12. 8.2.5 Charles River Recent Developments
  13. 8.3 LabCorp
  14. 8.3.1 LabCorp Company Information
  15. 8.3.2 LabCorp Business Overview
  16. 8.3.3 LabCorp Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 LabCorp Bioanalytical Testing Product Portfolio
  18. 8.3.5 LabCorp Recent Developments
  19. 8.4 Altasciences
  20. 8.4.1 Altasciences Company Information
  21. 8.4.2 Altasciences Business Overview
  22. 8.4.3 Altasciences Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Altasciences Bioanalytical Testing Product Portfolio
  24. 8.4.5 Altasciences Recent Developments
  25. 8.5 Intertek
  26. 8.5.1 Intertek Company Information
  27. 8.5.2 Intertek Business Overview
  28. 8.5.3 Intertek Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intertek Bioanalytical Testing Product Portfolio
  30. 8.5.5 Intertek Recent Developments
  31. 8.6 Celerion
  32. 8.6.1 Celerion Company Information
  33. 8.6.2 Celerion Business Overview
  34. 8.6.3 Celerion Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Celerion Bioanalytical Testing Product Portfolio
  36. 8.6.5 Celerion Recent Developments
  37. 8.7 ACM Global Laboratories
  38. 8.7.1 ACM Global Laboratories Company Information
  39. 8.7.2 ACM Global Laboratories Business Overview
  40. 8.7.3 ACM Global Laboratories Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ACM Global Laboratories Bioanalytical Testing Product Portfolio
  42. 8.7.5 ACM Global Laboratories Recent Developments
  43. 8.8 Q2 Solutions
  44. 8.8.1 Q2 Solutions Company Information
  45. 8.8.2 Q2 Solutions Business Overview
  46. 8.8.3 Q2 Solutions Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Q2 Solutions Bioanalytical Testing Product Portfolio
  48. 8.8.5 Q2 Solutions Recent Developments
  49. 8.9 WuXi AppTec
  50. 8.9.1 WuXi AppTec Company Information
  51. 8.9.2 WuXi AppTec Business Overview
  52. 8.9.3 WuXi AppTec Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 WuXi AppTec Bioanalytical Testing Product Portfolio
  54. 8.9.5 WuXi AppTec Recent Developments
  55. 8.10 SGS
  56. 8.10.1 SGS Company Information
  57. 8.10.2 SGS Business Overview
  58. 8.10.3 SGS Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SGS Bioanalytical Testing Product Portfolio
  60. 8.10.5 SGS Recent Developments
  61. 8.11 Ardena
  62. 8.11.1 Ardena Company Information
  63. 8.11.2 Ardena Business Overview
  64. 8.11.3 Ardena Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ardena Bioanalytical Testing Product Portfolio
  66. 8.11.5 Ardena Recent Developments
  67. 8.12 VTT
  68. 8.12.1 VTT Company Information
  69. 8.12.2 VTT Business Overview
  70. 8.12.3 VTT Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VTT Bioanalytical Testing Product Portfolio
  72. 8.12.5 VTT Recent Developments
  73. 8.13 ICON
  74. 8.13.1 ICON Company Information
  75. 8.13.2 ICON Business Overview
  76. 8.13.3 ICON Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ICON Bioanalytical Testing Product Portfolio
  78. 8.13.5 ICON Recent Developments
  79. 8.14 Simbec-Orion
  80. 8.14.1 Simbec-Orion Company Information
  81. 8.14.2 Simbec-Orion Business Overview
  82. 8.14.3 Simbec-Orion Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Simbec-Orion Bioanalytical Testing Product Portfolio
  84. 8.14.5 Simbec-Orion Recent Developments
  85. 8.15 Medpace
  86. 8.15.1 Medpace Company Information
  87. 8.15.2 Medpace Business Overview
  88. 8.15.3 Medpace Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Medpace Bioanalytical Testing Product Portfolio
  90. 8.15.5 Medpace Recent Developments
  91. 8.16 Frontage
  92. 8.16.1 Frontage Company Information
  93. 8.16.2 Frontage Business Overview
  94. 8.16.3 Frontage Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Frontage Bioanalytical Testing Product Portfolio
  96. 8.16.5 Frontage Recent Developments
  97. 8.17 Pharmaron
  98. 8.17.1 Pharmaron Company Information
  99. 8.17.2 Pharmaron Business Overview
  100. 8.17.3 Pharmaron Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pharmaron Bioanalytical Testing Product Portfolio
  102. 8.17.5 Pharmaron Recent Developments
  103. 8.18 Veeda
  104. 8.18.1 Veeda Company Information
  105. 8.18.2 Veeda Business Overview
  106. 8.18.3 Veeda Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Veeda Bioanalytical Testing Product Portfolio
  108. 8.18.5 Veeda Recent Developments
  109. 8.19 GenScript
  110. 8.19.1 GenScript Company Information
  111. 8.19.2 GenScript Business Overview
  112. 8.19.3 GenScript Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 GenScript Bioanalytical Testing Product Portfolio
  114. 8.19.5 GenScript Recent Developments
  115. 8.20 Sino Biological
  116. 8.20.1 Sino Biological Company Information
  117. 8.20.2 Sino Biological Business Overview
  118. 8.20.3 Sino Biological Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sino Biological Bioanalytical Testing Product Portfolio
  120. 8.20.5 Sino Biological Recent Developments
  121. 8.21 Tigermed
  122. 8.21.1 Tigermed Company Information
  123. 8.21.2 Tigermed Business Overview
  124. 8.21.3 Tigermed Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Tigermed Bioanalytical Testing Product Portfolio
  126. 8.21.5 Tigermed Recent Developments
  127. 8.22 Medicilon
  128. 8.22.1 Medicilon Company Information
  129. 8.22.2 Medicilon Business Overview
  130. 8.22.3 Medicilon Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Medicilon Bioanalytical Testing Product Portfolio
  132. 8.22.5 Medicilon Recent Developments
  133. 8.23 Scinovo
  134. 8.23.1 Scinovo Company Information
  135. 8.23.2 Scinovo Business Overview
  136. 8.23.3 Scinovo Bioanalytical Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Scinovo Bioanalytical Testing Product Portfolio
  138. 8.23.5 Scinovo Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst